CD79B and lymphoma: Another interesting finding is that the expression of CXCL10, reported to be highly expressed in lymphoma patients [59], was decreased, while the expression of ALOX5 was increased; this enzyme is suppressed by BCR signaling and has previously been reported to be increased in TMD8 cells by knockdown of CD79B and by ibrutinib [60].